Custom Cloning Service
A one-stop source for research solutions, abm offers custom services for all your cloning needs including Gene Synthesis, Cloning and Mutagenesis aimed to reduce the time, effort and money spent by researchers.
Looking for a Custom Vector? Click the Inquire button below or design your own using our Plasmid Planner.
Additional Resources:
"Of all the companies I have reached out to, abm has been the best in terms of explaining the technology and how it fits my application."
Tim Erickson, Ingenovax, Custom Cloning ServiceService Details
Core Services
Service Name | Description | Unit | Cat. No. | Price |
---|---|---|---|---|
Economy Gene Synthesis & Subcloning |
|
1.0 μg | C078 | $250.00 |
Gene Synthesis |
|
1.0 μg | C098 | Starting at USD$0.18/bp* |
Subcloning Service I |
|
1.0 μg | C096 | $125.00 |
Subcloning Service II |
|
1.0 μg | C097 | $225.00 |
Site-directed Mutagenesis |
|
1.0 μg | C047 | $150.00 |
Additional Charge for Extra 1 kbp |
|
N/A | C100 | $100.00 |
Promoter Change Service |
|
1.0 μg | C126 | $350.00 |
Tag Addition/Removal Service (≤ 30 bp) |
|
1.0 μg | C127 | $250.00 |
Tag Addition/Removal Service (> 30 bp) * |
|
1.0 μg | C128 | $350.00 |
Reporter Addition/Removal Service |
|
1.0 μg | C129 | $350.00 |
Antibiotic Switching Service |
|
1.0 μg | C140 | $350.00 |
ADD-ON-SERVICES
Service Name | Description | Unit | Cat. No. | Price |
---|---|---|---|---|
DNA Sequencing |
|
Single Reaction | C199 | $7.50 |
Bacterial Agar Stab |
|
1 clone | C315 | $40.00 |
Plasmid Amplification (10-20 μg) |
|
10-20 μg | C309 | $75.00/prep |
Plasmid Amplification (80-100 μg) |
|
80-100 μg | C310 | $150.00/prep |
Additional Info
abm Vectors Available for Use in the Above ServicesCloning into pUC57 or pORF is free of charge; for use of other abm vector backbones the charge is $350 (Cat. No. C318). Here is a selected list of expression vectors. Cloning into retrovirus, HSV, baculovirus, and much more is also offered at abm.
Lentiviral System | AAV System | Adenoviral System | Protein Expression System |
---|---|---|---|
pLenti-III-HA | pAAV-G-CMV-amp | pShuttle (+) | pPB-C-His |
pLenti-EF1a-GFP-2A-Puro | pAAV-G-EF1a-hGH-amp | pShuttle (-) | pPB-His-MBP |
pLenti-CMV-GFP-2A-Puro | pAAV-G-PGK-hGH-amp | pShuttle-HA | pPB-His GST |
pLenti-CMV-RFP-2A-Puro | pAAV-G-CAGGS-hGH-amp | pShuttle-His | pPB-N-His |
pLenti-Bi-cistronic | pPromoter | pPM-C-His | |
pLenti-Tri-cistronic | pPM-C-HA | ||
pLenti-III-EF1α | pPM-N-D-C-HA | ||
pLenti-III-PGK | pPM-N-D-C-His | ||
pLenti-III-UbC | |||
pLenti-Promoterless | |||
Additional lentiviral vectors available. | Additional vectors available. | Additional vectors available. |
- Viral packaging services available upon request.
- We can also insert your gene in an inverse orientation, flanked by double lox sites, so that it will only flip for expression in cells that express Cre recombinase.
- Try tissue-specific promoters for controlled gene expression.
Related Products
FAQs
For the Antibiotic Switching Service, can I change the gene to a resistance marker other than Puromycin or Neomycin? |
Yes, we can certainly look into this for you. Please email technical@abmgood.com for further information.
|
Citations
01 | Wen, Z et al. "MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting V." PLoS One 9(9):e104666 (2014). DOI: 10.1371/journal.pone.0104666 PubMed: 25251394 Application: Inhibitor miRNA lentivector. |
02 | Laryea, G et al. "Site-specific modulation of brain glucocorticoid receptor and corticotropin-releasing hormone expression using lentiviral vectors." Mol Cell Endocrinol 371(1-2):160-5 (2013). DOI: 23261985 PubMed: 10.1016/j.mce.2012.12.005 Application: EF1a lentivector. |
03 | Das, A et al. "Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation.." J Immunol 192(3):1120-9 (2014). DOI: 10.4049/jimmunol.1300613 PubMed: 24391209 Application: Transduction. |
04 | Eagleman, DE et al." Unbiased proteomic screening identifies a novel role for the E3 ubiquitin ligase Nedd4-2 in translational suppression during ER stress." J Neurochem 157(6):1809-1820 (2021). DOI: 10.1111/jnc.15219 PubMed: 33064840 Application: Site Directed Mutagenesis. |